Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Joop E. Arends"'
Autor:
Patrick G. A. Oomen, Charlotte S. Hakkers, Joop E. Arends, Guido E. L. van der Berk, Pascal Pas, Andy I. M. Hoepelman, Berend J. van Welzen, Stefan du Plessis
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 5, Pp 1067-1082 (2024)
Abstract Introduction It is unclear whether neurotoxicity due to the antiretroviral drug efavirenz (EFV) results in neurocognitive impairment in people living with HIV (PLWH). Previously, we found that discontinuing EFV was associated with improved p
Externí odkaz:
https://doaj.org/article/89b5bb64f5f64621904886fd09fc1739
Autor:
Kris Hage, Marita van de Kerkhof, Anders Boyd, Joanne M. Carson, Astrid M. Newsum, Amy Matser, Marc van der Valk, Kees Brinkman, Joop E. Arends, Fanny N. Lauw, Bart J. A. Rijnders, Arne van Eeden, Marianne Martinello, Gail V. Matthews, Janke Schinkel, Maria Prins
Publikováno v:
Pathogens, Vol 12, Iss 10, p 1248 (2023)
We assessed the predictive capacity of the HCV-MOSAIC risk score, originally developed for primary early HCV infection, as a screening tool for HCV reinfection in 103 men who have sex with men (MSM) with HIV using data from the MOSAIC cohort, includi
Externí odkaz:
https://doaj.org/article/9d5ba0e6445c403f8af77efbeb5f24f9
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The hepatitis C virus (HCV) infection is a candidate disease for micro-elimination. Accurate baseline HCV prevalence estimation is essential to monitor progress to micro-elimination but can be methodologically challenging in low-e
Externí odkaz:
https://doaj.org/article/38829b21a2b646d8ba6e4125b2830865
Autor:
Stephanie Popping, Lize Cuypers, Mark A. A. Claassen, Guido E. van den Berk, Anja De Weggheleire, Joop E. Arends, Anne Boerekamps, Richard Molenkamp, Marion P. G. Koopmans, Annelies Verbon, Charles A. B. Boucher, Bart Rijnders, David A. M. C. van de Vijver
Publikováno v:
Viruses, Vol 14, Iss 9, p 1953 (2022)
Background: In the Netherlands, unrestricted access to direct-acting antivirals (DAAs) halved the incidence of acute hepatitis C virus (HCV) infections among HIV-infected men who have sex with men (MSM). To develop strategies that can further reduce
Externí odkaz:
https://doaj.org/article/da22468f481a430d87c80df0148ef996
Autor:
Patricia A. M. Kracht, Elisabeth A. de Gee, Agnes van der Poel, Marc A. M. T. Verhagen, Andy I. M. Hoepelman, Esther A. Croes, Joop E. Arends
Publikováno v:
Harm Reduction Journal, Vol 16, Iss 1, Pp 1-10 (2019)
Abstract Background People who inject drugs (PWID) are disproportionally affected by the hepatitis C virus (HCV) infection. In the Netherlands, active HCV transmission in PWID has practically been halted but uptake of HCV testing and linkage to care
Externí odkaz:
https://doaj.org/article/bed9f0e432a34a57af1f663443b682d9
Autor:
Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 1, Pp 33-50 (2019)
Abstract The burden of liver-related morbidity remains high among HIV-infected patients, despite advances in the treatment of HIV and viral hepatitis. Especially, the impact of non-alcoholic fatty liver disease (NAFLD) is significant with a prevalenc
Externí odkaz:
https://doaj.org/article/ad3bf00ecdfa4f989d07896434ccf824
Publikováno v:
Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 407-419 (2018)
Abstract Elimination of the three blood-borne viruses—human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV)—as public health issues may be plausible in the near future. Spectacular advances have been made with the introducti
Externí odkaz:
https://doaj.org/article/9216e79d45284867938e13c5d4f5d507
Autor:
Tongai Gibson Maponga, Monique I. Andersson, Christoffel J. van Rensburg, Joop E. Arends, Jantjie Taljaard, Wolfgang Preiser, Richard H. Glashoff
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Co-infection with HIV negatively impacts the progression of chronic hepatitis B virus (HBV) infection, including causing rapid progression to liver fibrosis. Sub-Saharan Africa represents arguably the most important intersection o
Externí odkaz:
https://doaj.org/article/41db528225024ac98c62ff9a0ef6b037
Autor:
Faydra I. Lieveld, Niels Swaans, Astrid M. Newsum, Cynthia K.Y. Ho, Janke Schinkel, Richard Molenkamp, Jan T.M. van der Meer, Joop E. Arends, Andy I.M. Hoepelman, Anne M.J. Wensing, Peter D. Siersema, Karel J. van Erpecum, Greet J. Boland
Publikováno v:
Annals of Hepatology, Vol 15, Iss 5, Pp 696-704 (2016)
Background and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV) coinfected patients are scarce. We assessed frequencies o
Externí odkaz:
https://doaj.org/article/ef7f7c7b6ddf4c0f9a907447d000c29e
Autor:
Soeradj Harkisoen, M.D., Joop E. Arends, Karel J. van Erpecum, Anneke van den Hoek, Andy I.M. Hoepelman
Publikováno v:
Annals of Hepatology, Vol 11, Iss 2, Pp 164-171 (2012)
Chronic hepatitis B has a variable course in disease activity with a risk of clinical complications like liver cirrhosis and hepatocellular carcinoma. As clinical symptoms present in a late stage of the disease, identification of risk factors is impo
Externí odkaz:
https://doaj.org/article/735aac10e4354d81bb6159aba0fa50d0